Luliconazole
CAS 187164-19-8
Visão geral
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan
A Anant Labs fabrica e fornece impurezas de Luliconazole de alta qualidade para o mercado global. Nossas impurezas EP de Luliconazole são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.







